Product
Supplier
Encyclopedia
Inquiry
Pimavanserin Tartrate API buy - large image1
Pimavanserin Tartrate API buy - image1

Pimavanserin Tartrate API

1 Inquiries

Unit Price: Get Latest Price
CAS No.:

706782-28-7

Grade:

Pharmaceutical Grade

Content:

99%

Packaging:

25kg/Cardboard Drum

Sample Available:

Yes

Price valid (until):

2023-05-25

Company Type:
Manufactory
Location:
China
Payment Terms:
TT against copy of documents,L/C
Average Lead Time:
20 days
Qualification:
Main Products:

Betahistine Mesylate,Azilsartan Medoxomil Potassium,Pimavanserin Tartrate,Iguratimod

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  



    ECHEMI Editorial Reference
    Pimavanserin, developed by San Diego-based Acadia Pharmaceuticals, is a selective and potent serotonin 2A (5-HT2A) receptor inverse agonist. The USFDA approved this once-daily drug to treat the delusions and hallucinations associated with psychosis as a function of Parkinson’s disease. Pimavanserin has a unique mechanism of action relative to other antipsychotics, behaving as a selective inverse agonist of the serotonin 5-HT2A receptor while exhibiting 40-fold selectivity over the 5-HT2C receptor and having no significant affinity or activity with the 5-HT2B or dopamine receptors.
    ChEBI: A tartrate salt that is the hemitartrate salt of pimavanserin. An atypical antipsychotic that is used for treatment of hallucinations and delusions associated with Parkinson's disease.

    Basic Info
    Product Name:

    Unii-na83F1sjsr

    Other Name:

    N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1);N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide;Unii-na83F1sjsr;PiMavanserin Tartrate;Pimavanserin tartrate or ACP 103;ACP-103;BVF-048;Nuplazid

    CAS No.:

    706782-28-7

    Molecular Formula:

    C29H40FN3O8

    InChIKeys:

    XTTVNKCYECPJOF-MVELKYERNA-N

    Molecular Weight:

    577.65

    EC Number:

    1806241-263-5

    Color/Form:

    White to off-white

    HScode:

    29299090

    Categories:

    Other Chemical Drugs

    Characteristics
    Critical Temperature & Pressure:

    Store at -20°C

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Betahistine Mesylate,Azilsartan Medoxomil Potassium,Pimavanserin Tartrate,Iguratimod

    Location:

    Building 4, Juanhu Int. Sci & Innovation Park, No. 500, Shuiyueting East Road, Xishi Street, Haining, Jiaxing, Zhejiang

    Payment Terms:

    TT against copy of documents,L/C

    Average lead Time:

    20 days

    Total Annual Revenue:

    $25 million-$50 million

    Total Employees:

    201-300

    Year of Establishment:

    2021

    Alicorn Pharmaceutical is a leading Manufactory supplier of Iguratimod, AR-13324 (mesylate), Safinamide based in Jiaxing, Zhejiang, China. With a commitment to quality and customer satisfaction, Alicorn Pharmaceutical has become a trusted name in the industry. Our product line includes a range of high-quality Iguratimod, AR-13324 (mesylate), Safinamide, which are available at competitive prices. Alicorn Pharmaceutical has established itself as a reliable supplier of chemical products on the echemi.com.

  • Inquiry History
    1 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    Pimavanserin tartrate

    2 G Feb 1, 2024
    Post an enquiry for this product

More from this Seller

pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.